Nanomedicines demand tight control over particle properties, reproducibility, and scalability, yet conventional batch methods often struggle to deliver all three.

In this whitepaper, Ardena’s nanomedicines experts Mark van Eldijk and Andy Bänziger explore how flow manufacturing can enable more consistent nanoparticle production, simplify scale-up, and support robust development pathways from early-stage research through GMP manufacturing.

The paper includes a practical case study using a multi-inlet vortex mixer (MIVM) for liposome production, showing how key process parameters influence particle size and polydispersity.

Download the whitepaper to learn:

  • Why flow manufacturing improves reproducibility compared to batch processes

  • How continuous processing supports scalable nanoparticle production

  • A real formulation case study demonstrating parameter-driven control

Get the whitepaper by filling in the form.

Interested in reading the full resource?

Please fill out the form to unlock the rest of the content.

Latest Resources

Our team members share deep, scientific understanding and insights into their respective fields of expertise.

Want to hear more from Ardena?

Sign up to receive drug development insights, the latest on industry trends & Ardena news.

Stay up to date with our latest news and announcements.
Get deep, scientific understanding and insights into our key fields of expertise.
See the events we're attending and register for webinars we're hosting.